SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-021330
Filing Date
2021-04-28
Accepted
2021-04-28 16:03:25
Documents
10
Period of Report
2021-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A urgn-def14a_20210607.htm DEF 14A 1160918
2 GRAPHIC gcnbklo15dzf000001.jpg GRAPHIC 34495
3 GRAPHIC gcnbklo15dzf000003.jpg GRAPHIC 118563
4 GRAPHIC gcnbklo15dzf000006.jpg GRAPHIC 100796
5 GRAPHIC gcnbklo15dzf000009.jpg GRAPHIC 147268
6 GRAPHIC gcnbklo15dzf000008.jpg GRAPHIC 147672
7 GRAPHIC gcnbklo15dzf000002.jpg GRAPHIC 4878
8 GRAPHIC gcnbklo15dzf000007.jpg GRAPHIC 151678
9 GRAPHIC gcnbklo15dzf000004.jpg GRAPHIC 112490
10 GRAPHIC gcnbklo15dzf000005.jpg GRAPHIC 323877
  Complete submission text file 0001564590-21-021330.txt   2735308
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38079 | Film No.: 21864168
SIC: 2834 Pharmaceutical Preparations